SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:90d6c998-b27f-43eb-996a-5aa83f481fa5"
 

Search: onr:"swepub:oai:lup.lub.lu.se:90d6c998-b27f-43eb-996a-5aa83f481fa5" > The gut microbiota ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

The gut microbiota and diabetes : research, translation, and clinical applications – 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum

Byndloss, Mariana (author)
Vanderbilt University Medical Center
Devkota, Suzanne (author)
Cedars-Sinai Medical Center
Duca, Frank (author)
University of Arizona
show more...
Niess, Jan Hendrik (author)
University of Basel
Nieuwdorp, Max (author)
Academic Medical Center of University of Amsterdam (AMC)
Orho-Melander, Marju (author)
Lund University,Lunds universitet,Diabetes - kardiovaskulär sjukdom,Forskargrupper vid Lunds universitet,Diabetes - Cardiovascular Disease,Lund University Research Groups
Sanz, Yolanda (author)
CSIC - Institute Of Agrochemistry And Food Technology (IATA)
Tremaroli, Valentina (author)
University of Gothenburg
Zhao, Liping (author)
Rutgers University: The State University of New Jersey
show less...
 (creator_code:org_t)
2024
2024
English.
In: Diabetologia. - 0012-186X.
  • Research review (peer-reviewed)
Abstract Subject headings
Close  
  • This article summarises the state of the science on the role of the gut microbiota (GM) in diabetes from a recent international expert forum organised by Diabetes, Diabetes Care, and Diabetologia, which was held at the European Association for the Study of Diabetes 2023 Annual Meeting in Hamburg, Germany. Forum participants included clinicians and basic scientists who are leading investigators in the field of the intestinal microbiome and metabolism. Their conclusions were as follows: (1) the GM may be involved in the pathophysiology of type 2 diabetes, as microbially produced metabolites associate both positively and negatively with the disease, and mechanistic links of GM functions (e.g. genes for butyrate production) with glucose metabolism have recently emerged through the use of Mendelian randomisation in humans; (2) the highly individualised nature of the GM poses a major research obstacle, and large cohorts and a deep-sequencing metagenomic approach are required for robust assessments of associations and causation; (3) because single time point sampling misses intraindividual GM dynamics, future studies with repeated measures within individuals are needed; and (4) much future research will be required to determine the applicability of this expanding knowledge to diabetes diagnosis and treatment, and novel technologies and improved computational tools will be important to achieve this goal.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)

Keyword

Butyrate
Faecal microbiota transplantation
Gastrointestinal microbiota
Gastrointestinal tract microbiology
Gut microbiota
Large intestine microbiota
Metagenomics
Microbiota metabolites
Review
Short-chain fatty acids
Small intestine microbiota

Publication and Content Type

for (subject category)
ref (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view